Sort
59,101 grants matching “hypertension”
Examination of Genetic and GxE Effects in the Family and Community Health Studies
$592,584Robert A Philibert · University Of Iowa · R01 · FY2010 · MH
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
$592,550Sanjay Srivastava · University Of Louisville · P42 · FY2025 · ES
Pilot Trial of Carvedilol in Alzheimer's Disease
$592,548Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · AG
Movement-Responsive Cage for Simultaneous Pharmacology Studies in Minipigs
$592,548R. Tyler Degraw · Bioanalytical Systems, Inc. (Basi) · R44 · FY2008 · RR
Gut microbiome, aging and cardiometabolic diseases in American Indians
$592,471Jinying Zhao · University Of Florida · R01 · FY2024 · AG
Neighborhoods and Cardiovascular Risk in a Multiethnic Cohort
$592,445Lynda D Lisabeth · University Of Michigan At Ann Arbor · R01 · FY2013 · HL
Intrinsic and synaptic determinants of SNc DA neuron activity and vulnerability
$592,324Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2011 · NS
Urotensin II and renal insufficiency in growth-restricted infants.
$592,319Adebowale Adebiyi · University Of Missouri-Columbia · R01 · FY2024 · DK
S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung
$592,303Thomas Michael Raffay · Case Western Reserve University · R01 · FY2025 · HL
S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung
$592,303Thomas Michael Raffay · Case Western Reserve University · R01 · FY2024 · HL
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults
$592,300Glen Taksler · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AG
Genetic and Environmental Effects on Clinical Cardiovascular Events in a Large Co
$592,293Redford B Williams · Duke University · P01 · FY2010 · HL
Angiotensins, Prostaglandins-Adrenergic Interactions
$592,283Kafait U Malik · University Of Tennessee Health Sci Ctr · R01 · FY2013 · HL
Translating Research into Prevention of Diabetes (TRIP Diabetes)
$592,266David C Goff · Wake Forest University Health Sciences · R18 · FY2009 · DK
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
$592,247Flemming Forsberg · Thomas Jefferson University · R01 · FY2014 · DK
Contingency Management for Initiating Smoking Abstinence
$592,240William White · University Of Connecticut Sch Of Med/Dnt · R01 · FY2010 · DA
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
$592,231Alexander Egbe · Mayo Clinic Rochester · R01 · FY2021 · HL
Heme toxicity and vaso-occlusion in sickle cell disease
$592,192Gregory M Vercellotti · University Of Minnesota · R01 · FY2015 · HL
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
$592,127Barry Ira Freedman · Wake Forest University Health Sciences · R01 · FY2014 · DK
Evaluating Control of Hypertension - Effect of Social Determinants (ECHOES)
$592,046Jennifer E Devoe · Oregon Health & Science University · R01 · FY2019 · HL
Polygenic Risk of Disease in Populations of Diverse Ancestry
$592,026Daniel J. Schaid · Mayo Clinic Rochester · U01 · FY2025 · HG
Polygenic Risk of Disease in Populations of Diverse Ancestry
$592,026Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2024 · HG
Genotype-Phenotype Relationships in Fragile X Families
$592,020Randi J Hagerman · University Of California At Davis · R01 · FY2020 · HD
Modeling Central Autonomic Regulatory Network Adaptation to Hypertension
$592,009James Schwaber · Thomas Jefferson University · R01 · FY2015 · HL
Footwear-based physical activity biofeedback device for weight management
$592,006Harold Baeverstad · Smartmove, Inc. · R44 · FY2012 · DK